Es gab 50 kürzliche Insider-Transaktionen für Vaccitech plc (VACC), darunter 37 Käufe und 12 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $17.41M und die gesamten Insider-Verkäufe auf $338.75K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Enright William, Griffiths Graham, Brown Gemma. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VACC
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-01-02 |
Enright William |
Chief Executive Officer |
RSU-Zuteilung |
443,981 |
$3.70 |
$1.64M |
443,981 |
| 2024-01-02 |
Griffiths Graham |
Chief Business Officer |
RSU-Zuteilung |
96,500 |
$3.70 |
$357.05K |
96,500 |
| 2024-01-02 |
Brown Gemma |
Chief Financial Officer |
RSU-Zuteilung |
193,000 |
$3.70 |
$714.1K |
193,000 |
| 2024-01-02 |
Pelletier Nadege |
Chief Scientific Officer |
RSU-Zuteilung |
105,000 |
$3.70 |
$388.5K |
105,000 |
| 2023-06-26 |
Scheeren Joseph |
Director |
Informierter Kauf |
10,000 |
$2.44 |
$24.4K |
23,000 |
| 2023-05-25 |
Wright Robin |
Director |
Informierter Kauf |
13,750 |
$2.66 |
$36.61K |
48,256 |
| 2023-05-11 |
Dawes Karen A |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Phillips Anne M. |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Hammacher Alex |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Morgon Pierre A. |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Wright Robin |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Scheeren Joseph |
Director |
RSU-Zuteilung |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-03-27 |
Enright William |
Chief Executive Officer |
Informierter Verkauf |
15,000 |
$2.42 |
$36.3K |
728,454 |
| 2023-02-01 |
Pelletier Nadege |
Chief Scientific Officer |
RSU-Zuteilung |
485,000 |
$2.90 |
$1.41M |
485,000 |
| 2023-01-30 |
Pelletier Nadege |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-01-03 |
Enright William |
Chief Executive Officer |
RSU-Zuteilung |
440,000 |
$2.40 |
$1.06M |
440,000 |
| 2023-01-03 |
Griffiths Graham |
Chief Business Officer |
RSU-Zuteilung |
105,000 |
$2.40 |
$252K |
105,000 |
| 2023-01-03 |
Ellis Christopher |
Chief Operating Officer |
RSU-Zuteilung |
105,000 |
$2.40 |
$252K |
105,000 |
| 2023-01-03 |
Brown Gemma |
Chief Financial Officer |
RSU-Zuteilung |
33,100 |
$2.40 |
$79.44K |
33,100 |
| 2023-01-03 |
Marshall Margaret |
Chief Medical Officer |
RSU-Zuteilung |
60,000 |
$2.40 |
$144K |
60,000 |
| 2023-01-03 |
Evans Thomas George |
Fmr Chief Scientific Officer |
RSU-Zuteilung |
125,000 |
$2.40 |
$300K |
125,000 |
| 2022-09-30 |
M&g Investment Management Ltd |
Director |
Sonstige (Kauf) |
4,108,752 |
- |
- |
5,197,349 |
| 2022-09-30 |
M&g Alternatives Investment Management Ltd |
Director |
Sonstige (Verkauf) |
4,108,752 |
- |
- |
- |
| 2022-09-26 |
Brown Gemma |
Chief Financial Officer |
RSU-Zuteilung |
334,000 |
$3.07 |
$1.03M |
334,000 |
| 2022-08-25 |
Griffiths Graham |
Chief Business Officer |
Informierter Verkauf |
10,000 |
$7.39 |
$73.87K |
104,209 |
| 2022-08-24 |
Ellis Christopher |
Chief Operating Officer |
Informierter Verkauf |
25,000 |
$7.07 |
$176.71K |
75 |
| 2022-08-17 |
Griffiths Graham |
Chief Business Officer |
Informierter Verkauf |
500 |
$4.76 |
$2.38K |
114,209 |
| 2022-08-17 |
Ellis Christopher |
Chief Operating Officer |
Informierter Verkauf |
2,175 |
$4.84 |
$10.53K |
75 |
| 2022-08-15 |
Griffiths Graham |
Chief Business Officer |
Informierter Verkauf |
1,220 |
$4.82 |
$5.88K |
114,709 |
| 2022-08-15 |
Ellis Christopher |
Chief Operating Officer |
Informierter Verkauf |
2,200 |
$4.78 |
$10.51K |
75 |
| 2022-08-12 |
Griffiths Graham |
Chief Business Officer |
Informierter Verkauf |
5,000 |
$4.50 |
$22.5K |
118,329 |
| 2022-06-28 |
Ellis Christopher |
Chief Operating Officer |
Informierter Verkauf |
5 |
$6.00 |
$30.00 |
75 |
| 2022-06-23 |
Griffiths Graham |
Chief Business Officer |
Optionsausübung (Verkauf) |
1,931 |
- |
- |
- |
| 2022-06-15 |
Dawes Karen A |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Phillips Anne M. |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Hammacher Alex |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Morgon Pierre A. |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Wright Robin |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Scheeren Joseph |
Director |
RSU-Zuteilung |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-04-01 |
Scheeren Joseph |
Director |
Informierter Kauf |
10,000 |
$5.09 |
$50.9K |
13,000 |
| 2022-03-31 |
Hammacher Alex |
Director |
Informierter Kauf |
2,000 |
$5.14 |
$10.28K |
3,000 |
| 2022-01-03 |
Enright William |
Chief Executive Officer |
RSU-Zuteilung |
359,605 |
$11.12 |
$4M |
359,605 |
| 2022-01-03 |
Egorov Georgy |
Chief Financial Officer |
RSU-Zuteilung |
114,000 |
$11.12 |
$1.27M |
114,000 |
| 2022-01-03 |
Griffiths Graham |
Chief Business Officer |
RSU-Zuteilung |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Marshall Margaret |
Chief Medical Officer |
RSU-Zuteilung |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Ellis Christopher |
Chief Operating Officer |
RSU-Zuteilung |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Evans Thomas George |
Chief Scientific Officer |
RSU-Zuteilung |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2021-12-31 |
Hammacher Alex |
Director |
Informierter Kauf |
1,000 |
$10.86 |
$10.86K |
1,000 |
| 2021-12-22 |
Wright Robin |
Director |
Informierter Kauf |
10,000 |
$9.97 |
$99.7K |
34,506 |
| 2021-12-17 |
Griffiths Graham |
Chief Business Officer |
Optionsausübung (Verkauf) |
102,279 |
$0.00 |
$40.91 |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
